منابع مشابه
Unexpected side effect in mCRC
RATIONALE Regorafenib represents a treatment option in heavily pretreated patients affected by metastatic colorectal cancer (mCRC). Its safety profile is typical of small-molecule tyrosine-kinase inhibitors (TKIs) and most adverse events are manageable. PATIENT CONCERNS A 56 years-old Caucasian man affected by mCRC with normal hepatic reserve was treated with regorafenib as second-line treatm...
متن کاملFrequent Episodic Vertigo Is an Unexpected Side Effect of Flutamide
An 82-year-old male suffered from prostatic cancer five years ago. Since then, he has taken flutamide and was bothered with episodic vertigo (EV) every morning. In order to treat prostatic cancer, flutamide was not discontinued, but conservative treatment and life-style change were recommended. Finally, EV actually subsided. Herein, we report the rare case, in which EV was an unexpected side ef...
متن کاملANTI-EGFR THERAPIES IN mCRC
Table i shows the currently approved (2010) indications 1,2. Cetuximab and panitumumab have been investigated in a number of clinical trials in mcrc, with active research ongoing. In January 2010, a panel of Canadian oncologists with representation from across the country and with particular expertise in crc gathered to develop a consensus guideline on the use of anti-egfr therapies in the mana...
متن کاملA Rare and Unexpected Side-Effect of Cannabis Use: Abdominal Pain due to Acute Pancreatitis
Acute pancreatitis is a frequently encountered disorder in patients presenting to emergency units. Biliary system disorders, alcohol consumption, infections, and drugs are among the causes of acute pancreatitis. However, it is sometimes difficult to determine the etiology of this disorder, particularly if the patient does not wish to disclose his consumption of cannabis, the use of which is ill...
متن کاملDiplopia on vorapaxar: An unexpected side effect emerging only at second glance.
http://dx.doi.org/10.1160/TH16-02-0124 Thromb Haemost 2016; 115: 911–912 Dual antiplatelet treatment (DAPT) with the cyclooxygenase inhibitor aspirin and an adenosine diphosphate (ADP) P2Y12 receptor inhibitor represents the mainstay of pharmacological treatment in both stable coronary artery disease and acute coronary syndromes patients undergoing an invasive management by percutaneous coronar...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medicine
سال: 2017
ISSN: 0025-7974
DOI: 10.1097/md.0000000000006522